Amanote Research
Register
Sign In
Editorial: Can Hepatitis B Core-Related Antigen Be the New Biomarker for Hepatocellular Carcinoma in Nucleoside Analogue-Treated Chronic Hepatitis B?
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.15143
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
March 13, 2019
Authors
Lung-Yi Mak
Publisher
Wiley
Related search
Editorial: Can Hepatitis B Core-Related Antigen Be the New Biomarker for Hepatocellular Carcinoma in Nucleoside Analogue-Treated Chronic Hepatitis B? Author’s Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Hepatitis B Virus Infection and Hepatocellular Carcinoma: Correlation Between IgM Antibody to Hepatitis B Core Antigen, Hepatitis B E Antigen, and Hepatitis B DNA
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania
Hepatitis Monthly
Hepatology
Infectious Diseases
IgM-antibody Response to the Hepatitis B Core Antigen in Acute and Chronic Hepatitis B
Journal of Hygiene
Hepatitis B Core-Related Antigen Levels Are Associated With Response to Entecavir and Peginterferon Add-On Therapy in Hepatitis B E Antigen–positive Chronic Hepatitis B Patients
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Systematic Review With Meta-Analysis: Development of Hepatocellular Carcinoma in Chronic Hepatitis B Patients With Hepatitis B Surface Antigen Seroclearance
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Lack of Correlation Between the Antibody to Hepatitis B Core Antigen and Survival After Surgical Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Letter: Hepatocellular Carcinoma Risk After Hepatitis B Surface Antigen Seroclearance
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Mitofusin-2 Acts as Biomarker for Predicting Poor Prognosis in Hepatitis B Virus Related Hepatocellular Carcinoma
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases